These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10502792)

  • 1. HIV-1 entry inhibitors and virus emergence.
    D'Aquila RT; Hughes M; Johnson VA
    Nat Med; 1999 Oct; 5(10):1091. PubMed ID: 10502792
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral phenotype and CCR5 genotype.
    Michael NL; Moore JP
    Nat Med; 1999 Dec; 5(12):1330. PubMed ID: 10581048
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospects of HIV-1 entry inhibitors as novel therapeutics.
    Pierson TC; Doms RW; Pöhlmann S
    Rev Med Virol; 2004; 14(4):255-70. PubMed ID: 15248253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV chemokine receptor inhibitors as novel anti-HIV drugs.
    Princen K; Schols D
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic coreceptor analysis.
    Sierra S; Kaiser R; Thielen A; Lengauer T
    Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5 antagonists: a new tool in fighting HIV.
    Jülg B; Goebel FD
    J HIV Ther; 2005 Dec; 10(4):68-71. PubMed ID: 16519245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors.
    Arastéh K; Stocker H
    Eur J Med Res; 2007 Oct; 12(9):397-402. PubMed ID: 17933720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection.
    Maeda K; Nakata H; Ogata H; Koh Y; Miyakawa T; Mitsuya H
    Curr Opin Pharmacol; 2004 Oct; 4(5):447-52. PubMed ID: 15351348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New kinds of AIDS drugs inhibit HIV entry into the cell. Entry inhibitors soon for oral administration].
    Fätkenheuer G
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():46-8. PubMed ID: 16385874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV-1 coreceptors and the progress of anti-HIV-1 therapy associated with them].
    Xing H; Waeg Q; Xu X
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1577-81. PubMed ID: 12675055
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of co-receptor usage of HIV-1.
    Schuitemaker H; Kootstra NA
    Methods Mol Biol; 2005; 304():327-32. PubMed ID: 16061986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What's New in HIV/AIDS? Chemokine receptor antagonists: a new era of HIV therapy?
    Jülg B; Goebel FD
    Infection; 2005 Oct; 33(5-6):408-10. PubMed ID: 16258879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entry inhibitors: a race to the finish line.
    Proj Inf Perspect; 2006 Jan; (40):7-12. PubMed ID: 16718905
    [No Abstract]   [Full Text] [Related]  

  • 14. Pouncing on the chemokine receptor Chimera.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):13-24. PubMed ID: 11364629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The X4 files.
    Huff B
    GMHC Treat Issues; 2004; 18(7-8):4-6. PubMed ID: 15473042
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of receptors in the HIV-1 entry process.
    Jones R; Nelson M
    Eur J Med Res; 2007 Oct; 12(9):391-6. PubMed ID: 17933719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of HIV coreceptor tropism.
    Hoffmann C
    Eur J Med Res; 2007 Oct; 12(9):385-90. PubMed ID: 17933718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting chemokine receptors in HIV: a status report.
    Kuhmann SE; Hartley O
    Annu Rev Pharmacol Toxicol; 2008; 48():425-61. PubMed ID: 17937593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killing two birds with one drug: a new application for HIV-1 cell entry inhibitors in the treatment of metastatic cancer.
    Bachmann AS; Gamper I
    Hawaii Med J; 2005 Aug; 64(8):220-3. PubMed ID: 16156163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.